A5017918480- CAR-T cell therapy research
- Virus-based gene therapy research
- Chronic Lymphocytic Leukemia Research
- Acute Lymphoblastic Leukemia research
- Viral Infectious Diseases and Gene Expression in Insects
- Nanowire Synthesis and Applications
- Electromagnetic Fields and Biological Effects
- Biosimilars and Bioanalytical Methods
- Wireless Body Area Networks
- Reproductive System and Pregnancy
- Genetic factors in colorectal cancer
- Immune Cell Function and Interaction
- CRISPR and Genetic Engineering
- Cancer Research and Treatments
- Pregnancy and preeclampsia studies
- Synthesis and Biological Evaluation
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Antenna Design and Analysis
- Cancer-related Molecular Pathways
- Digestive system and related health
- Liver Disease Diagnosis and Treatment
- RNA Interference and Gene Delivery
- Mechanisms of cancer metastasis
- Pregnancy and Medication Impact
Sansure Biotech (China)
2024
University of Colorado Boulder
2020
Memorial Sloan Kettering Cancer Center
2012-2016
Sichuan University
2009-2011
657 Oslo
2011
West China Hospital of Sichuan University
2009
State Key Laboratory of Biotherapy
2009
CD19 CAR T cell therapy induces complete remissions in 88% of 16 adult patients with relapsed or refractory acute lymphoblastic leukemia.
Five adults with chemotherapy-refractory B-ALL were induced into molecular remissions after treatment CD19 CAR-targeted T cells.
Adoptive transfer of chimeric antigen receptor (CAR) engineered T cells is a promising emerging strategy to treat cancer patients. Large-scale manufacturing cGMP-grade CAR using patient selected and activated by CTS™ Dynabeads® CD3/CD28 (Dynabeads) followed transduction with retroviral vectors being used in the context many clinical trials our laboratory others. Although we have established robust protocol Dynabeads, it important explore alternative sources pre-empt supply chain limitations...
Purpose: The performance and clinical accuracy of combined SDC2/NDRG4 methylation were evaluated in diagnosing colorectal cancer (CRC) advanced adenoma. Methods: A total 2333 participants enrolled to assess the sensitivity specificity biomarkers CRC a multicenter trial through feces DNA tests. Results: showed excellent for detection biomarker research real world. Its detecting CRC, early adenoma 92.06%, 91.45% 62.61%, respectively. was 94.29%, with coincidence rate 88.28%. When interference...
Global System for Mobile Communications (GSM) is currently one of the most widely and demanding telecommunication applications in world. Researchers have reported that radiation from base stations may be dangerous to public health some human diseases are related RF fleld exposure. Considering past almost all EM assessments were focused on Maximum transmission power station, no statistical analyses been performed transmitted power's variation with tra-c. An accurate method predicting...
Pre-eclampsia (PE) is a common obstetric syndrome affecting about 9.4% of pregnant women in our country. The etiology and pathogenesis PE are not fully understood. Some literatures found that the onset was an imbalance maternal-fetal immune tolerance. Maternal system can recognize fetal alloantigen activation cell-mediated immunity which may play role PE. has helper T cell (Th)1/Th2. Recent data suggest Th17/regulatory (Treg) with predominance Th17 immunity. latest research progress...